Cargando…
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Middle East respiratory syndrome (MERS) is a deadly viral respiratory disease caused by MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven effective against this viral disease. In addition, no vaccine has been licensed to prevent MERS-CoV infection thus far. Theref...
Autores principales: | Yong, Chean Yeah, Ong, Hui Kian, Yeap, Swee Keong, Ho, Kok Lian, Tan, Wen Siang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688523/ https://www.ncbi.nlm.nih.gov/pubmed/31428074 http://dx.doi.org/10.3389/fmicb.2019.01781 |
Ejemplares similares
-
Infectious hematopoietic necrosis virus: advances in diagnosis and vaccine development
por: Yong, Chean Yeah, et al.
Publicado: (2019) -
Current diagnostic approaches to detect two important betacoronaviruses: Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Chong, Zhi Xiong, et al.
Publicado: (2021) -
An Influenza A Vaccine Based on the Extracellular Domain of Matrix 2 Protein Protects BALB/C Mice Against H1N1 and H3N2
por: Ong, Hui Kian, et al.
Publicado: (2019) -
Advances in the study of nodavirus
por: Yong, Chean Yeah, et al.
Publicado: (2017) -
Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles
por: Yong, Chean Yeah, et al.
Publicado: (2015)